Frontiers in Veterinary Science (Nov 2021)

Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism

  • Martina Načeradská,
  • Martina Načeradská,
  • Kateřina Návojová Horáčková,
  • Michaela Fridrichová

DOI
https://doi.org/10.3389/fvets.2021.773355
Journal volume & issue
Vol. 8

Abstract

Read online

A 6-month-old kitten, male, domestic shorthair cat was presented with dwarfism, ocular and nasal discharge, and Ascaris infestation. Congenital hyposomatotropism was diagnosed on the basis of serum level of insulin-like growth factor-1 (IGF-I). The cat was treated with human recombinant growth hormone for 9 weeks. After that, his liver enzymes became elevated, and the therapy was discontinued. His IGF-I levels were normal at the end of the therapy. Normal IGF-I was present 3 months after discontinuation of therapy with human recombinant growth hormone and even half a year after the discontinuation. All other comorbidities were addressed with the therapy. The cat is now the size of normal cats, living with the first author.

Keywords